Alzchem Group AG (XTER:ACT) Buildings And Improvements: €0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:ACT Alzchem Group AG XTER:ACT
68 GF Score
Price €159.50
Valuation Significantly Overvalued
View Full Analysis

What is Alzchem Group AG Buildings And Improvements?

Alzchem Group AG XTER:ACT -1.12% 68 Buildings And Improvements is €0.0 Mil as of Jun. 2026. GuruFocus rates XTER:ACT with a GF Score™ of 68/100 (Significantly Overvalued).

Alzchem Group AG's quarterly buildings and improvements declined from Dec. 2025 (€0.5 Mil) to Mar. 2026 (€0.0 Mil) but then stayed the same from Mar. 2026 (€0.0 Mil) to Jun. 2026 (€0.0 Mil).

Alzchem Group AG's annual buildings and improvements declined from Dec. 2023 (€0.2 Mil) to Dec. 2024 (€0.1 Mil) but then increased from Dec. 2024 (€0.1 Mil) to Dec. 2025 (€0.5 Mil).

Alzchem Group AG Buildings And Improvements Historical Data

* Premium members only.

The historical data trend for Alzchem Group AG's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alzchem Group AG Buildings And Improvements Chart

Alzchem Group AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.30 0.17 0.07 0.46

Alzchem Group AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.46 0.00 0.00
XTER:ACT
68GF Score
Alzchem Group AG XTER:ACT
Buildings And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alzchem Group AG Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

What does a Buildings And Improvements of €0.0 Mil mean?
Alzchem Group AG (XTER:ACT) has a Buildings And Improvements of €0.0 Mil as of Jun. 2026. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on Alzchem Group AG and its competitors.
Is Alzchem Group AG's Buildings And Improvements too high?
Alzchem Group AG's current Buildings And Improvements is €0.0 Mil. Overall, Alzchem Group AG has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alzchem Group AG's Buildings And Improvements compare to LIN and SHW?
Alzchem Group AG's Buildings And Improvements of €0.0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buildings And Improvements for a Chemicals company?
A good Buildings And Improvements depends on the Chemicals industry context. However, Buildings And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buildings And Improvements mean?
A high Buildings And Improvements can signal that a stock is expensive relative to its fundamentals. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on Alzchem Group AG and its competitors. Alzchem Group AG's current Buildings And Improvements is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzchem Group AG stock overvalued right now?
Based on GuruFocus' analysis, Alzchem Group AG (XTER:ACT) is currently considered Significantly Overvalued. The current Buildings And Improvements is €0.0 Mil. Alzchem Group AG's overall GF Score™ is 68/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buildings And Improvements calculated?
Buildings And Improvements is calculated from a company's financial statements. For Alzchem Group AG (XTER:ACT), the current Buildings And Improvements is €0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alzchem Group AG Business Description

Address Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from European Union.
68GF Score

Get the complete analysis for XTER:ACT

Buildings And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€159.50
Price